BRPI0411621A - métodos de uso de células derivados de tecido adiposo no aumento de transferência de gordura autóloga - Google Patents

métodos de uso de células derivados de tecido adiposo no aumento de transferência de gordura autóloga

Info

Publication number
BRPI0411621A
BRPI0411621A BRPI0411621-6A BRPI0411621A BRPI0411621A BR PI0411621 A BRPI0411621 A BR PI0411621A BR PI0411621 A BRPI0411621 A BR PI0411621A BR PI0411621 A BRPI0411621 A BR PI0411621A
Authority
BR
Brazil
Prior art keywords
methods
fat
derived cells
adipose tissue
transfer
Prior art date
Application number
BRPI0411621-6A
Other languages
English (en)
Inventor
Marc H Hedrick
John K Fraser
Original Assignee
Macropore Biosurgery Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macropore Biosurgery Inc filed Critical Macropore Biosurgery Inc
Publication of BRPI0411621A publication Critical patent/BRPI0411621A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

"MéTODOS DE USO DE CéLULAS DERIVADAS DE TECIDO ADIPOSO NO AUMENTO DE TRANSFERêNCIA DE GORDURA AUTóLOGA". São descritos métodos de tratamento de pacientes para condições tais como aumento dos seios, defeitos do tecido brando e incontinência urinária. Os métodos incluem a remoção de tecido adiposo de um paciente, o processamento de uma porção do tecido adiposo para se obter uma população substancialmente isolada de células regenerativas, a mistura das células regenerativas com uma outra porção de tecido adiposo para formar uma composição, e a administração da composição ao paciente do qual o tecido adiposo foi removido.
BRPI0411621-6A 2003-06-18 2004-06-18 métodos de uso de células derivados de tecido adiposo no aumento de transferência de gordura autóloga BRPI0411621A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47941803P 2003-06-18 2003-06-18
PCT/US2004/019611 WO2005011569A2 (en) 2003-06-18 2004-06-18 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer

Publications (1)

Publication Number Publication Date
BRPI0411621A true BRPI0411621A (pt) 2006-08-08

Family

ID=34115306

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411621-6A BRPI0411621A (pt) 2003-06-18 2004-06-18 métodos de uso de células derivados de tecido adiposo no aumento de transferência de gordura autóloga

Country Status (9)

Country Link
EP (1) EP1638507B1 (pt)
JP (1) JP4722041B2 (pt)
KR (1) KR101145508B1 (pt)
CN (1) CN101415451A (pt)
AU (1) AU2004260638A1 (pt)
BR (1) BRPI0411621A (pt)
CA (1) CA2529954A1 (pt)
DK (1) DK1638507T3 (pt)
WO (1) WO2005011569A2 (pt)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7771716B2 (en) 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
US9597395B2 (en) 2001-12-07 2017-03-21 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US20050095228A1 (en) 2001-12-07 2005-05-05 Fraser John K. Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
US8105580B2 (en) 2001-12-07 2012-01-31 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to promote wound healing
KR100811537B1 (ko) 2005-03-11 2008-03-20 양영일 지방조직 치료제의 조성, 이들 제조방법 및 그의 전달방법
US8622997B2 (en) 2005-03-23 2014-01-07 Ronald D. Shippert Tissue transfer method and apparatus
US9581942B1 (en) 2005-03-23 2017-02-28 Shippert Enterprises, Llc Tissue transfer method and apparatus
US7780649B2 (en) 2005-03-23 2010-08-24 Shippert Ronald D Tissue transplantation method and apparatus
US7794449B2 (en) 2005-03-23 2010-09-14 Shippert Ronald D Tissue transplantation method and apparatus
US8062286B2 (en) 2005-03-23 2011-11-22 Shippert Ronald D Tissue transplantation method and apparatus
US7789872B2 (en) 2005-03-23 2010-09-07 Shippert Ronald D Tissue transplantation method and apparatus
US20110206643A1 (en) * 2005-06-02 2011-08-25 In Motion Investment, Ltd. Automated Cell Therapy System
KR100764640B1 (ko) * 2006-03-08 2007-10-10 세원셀론텍(주) 지방조직 수복용 키트
JP5259929B2 (ja) * 2006-04-25 2013-08-07 株式会社カネカ 脂肪組織から幹細胞を採取するのに適した細胞分離装置、およびその方法
CN101473030A (zh) * 2006-06-15 2009-07-01 Rnl生物技术株式会社 含有来自人类脂肪组织的多塑性干细胞、成纤维细胞和脂肪或脂肪细胞的整容或整形组合物
JP5155530B2 (ja) * 2006-07-25 2013-03-06 株式会社カネカ 成体幹細胞分離・培養システム
US20100092432A1 (en) * 2006-08-08 2010-04-15 Takenori Ozaki Cell preparation containing multipotential stem cells originating in fat tissue
JP5196890B2 (ja) * 2007-06-29 2013-05-15 オリンパス株式会社 有核細胞回収装置および有核細胞の回収方法
JP2009095309A (ja) * 2007-10-18 2009-05-07 Olympus Corp 生体組織分解装置および生体組織分解方法
WO2010021993A1 (en) 2008-08-19 2010-02-25 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
FI20085839A0 (fi) * 2008-09-08 2008-09-08 Timo Ylikomi Menetelmiä ja välineitä pehmytkudosteknologiaan
US9284523B2 (en) * 2008-10-27 2016-03-15 Terumo Bct, Inc. Premounted fluid conveyance assembly for cell expansion system and method of use associated therewith
JP2010178830A (ja) * 2009-02-04 2010-08-19 Olympus Corp 生体移植材とその製造方法
KR101644534B1 (ko) * 2009-05-01 2016-08-01 비미니 테크놀로지스 엘엘씨 조직 및 세포 부유화 이식편의 최적화 시스템, 방법 및 조성물
KR101316573B1 (ko) * 2009-10-27 2013-10-15 도병록 재생성 세포 추출유닛 및 재생성 세포 추출시스템
US8673639B2 (en) * 2009-11-17 2014-03-18 Hee Young Lee Methods for isolating stem cells
CN102906250A (zh) * 2010-02-23 2013-01-30 赛巴纳医药有限公司 提高脂肪移植物存活率的方法和组合物
EP2556141B1 (en) 2010-04-09 2019-05-01 Terumo BCT, Inc. Air removal chamber for a cell expansion system and method of use associated therewith
WO2012048275A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
US8887770B1 (en) 2011-03-17 2014-11-18 Ronald D. Shippert Vessel fill control method and apparatus
CN102151153A (zh) * 2011-03-25 2011-08-17 吴成翰 外科手术过程中组织碎片的回收装置
US9433645B2 (en) * 2012-04-13 2016-09-06 Jeong Chan Ra Method and composition for preventing stem cell disruption and aggregation
US9468709B2 (en) 2012-11-12 2016-10-18 Shippert Enterprises, Llc Syringe fill method and apparatus
US9580678B2 (en) 2013-06-21 2017-02-28 The Regents Of The University Of California Microfluidic tumor tissue dissociation device
JP6383938B2 (ja) * 2014-02-04 2018-09-05 国立大学法人名古屋大学 高濃度脂肪組織由来間葉系幹細胞含有脂肪による声門閉鎖不全の治療
US20160361476A1 (en) * 2014-02-28 2016-12-15 Bdbc Sciences Corp. System for tissue manipulation
US10772997B2 (en) 2014-05-15 2020-09-15 Ronald D. Shippert Tissue parcelization method and apparatus
US9988599B2 (en) 2014-08-25 2018-06-05 Reviticell Holdings, Inc. Modular single-use kits and methods for preparation of biological material
EP3660374B1 (en) 2015-06-19 2022-08-17 ROCKWOOL International A/S Intumescent fire sleeve, coil of several intumescent fire sleeves and method for installation of an intumescent fire sleeve
US10722540B1 (en) 2016-02-01 2020-07-28 The Regents Of The University Of California Microfluidic device and method for shear stress-induced transformation of cells
JP7072228B2 (ja) 2016-06-08 2022-05-20 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 組織および細胞を処理するための方法および装置
CN106367320B (zh) * 2016-11-21 2023-11-14 上海美致臻生物医学科技有限公司 一种手动脂肪核心集群细胞、脂肪基质血管组分采集器
CN106860923A (zh) * 2017-01-24 2017-06-20 北京欧扬医疗美容门诊部有限公司 一种短期维持脂肪细胞活性的多功能自体脂肪移植装置
KR20190019001A (ko) 2017-08-16 2019-02-26 (주)제이월드 지방분리용 장치 및 지방분리용 장치를 이용한 지방세포 분리 방법
US11272996B2 (en) 2019-10-04 2022-03-15 Reviticell Holdings, Inc. Methods and devices for performing sequential procedures utilizing a standardized system
KR102091151B1 (ko) * 2019-10-08 2020-03-20 주식회사 로킷헬스케어 당뇨병성 족부병증 환자 맞춤형 피부 재생 시트의 제조방법 및 이를 이용하여 제조된 당뇨병성 족부병증 환자 맞춤형 피부 재생 시트
KR102586028B1 (ko) * 2019-10-08 2023-10-10 주식회사 로킷헬스케어 당뇨병성 족부병증 환자 맞춤형 피부 재생 시트의 제조방법 및 이를 이용하여 제조된 당뇨병성 족부병증 환자 맞춤형 피부 재생 시트
US20240042100A1 (en) * 2020-12-24 2024-02-08 Rokit Healthcare Inc. Method of manufacturing a tissue regeneration patch
FR3134959B1 (fr) * 2022-04-29 2024-05-03 Neosyad Procédé et machine de transplantation de graisse
FR3135200A1 (fr) * 2022-05-09 2023-11-10 Neosyad Dispositif de purification de tissu adipeux

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087570A (en) * 1988-05-10 1992-02-11 Weissman Irving L Homogeneous mammalian hematopoietic stem cell composition
FR2742662B1 (fr) 1995-12-21 1998-01-23 Centre Nat Rech Scient Anticorps anti-idiotypiques du facteur de croissance endotheliale vasculaire et leur utilisation comme medicaments
US6280473B1 (en) 1996-08-19 2001-08-28 Macropore, Inc. Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration
US5919234A (en) 1996-08-19 1999-07-06 Macropore, Inc. Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration
US6269716B1 (en) 1998-11-18 2001-08-07 Macropore, Inc. High-torque resorbable screws
CA2327789C (en) 1998-04-07 2007-09-04 Macropore, Inc. Membrane with tissue-guiding surface corrugations
US6777231B1 (en) * 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
AU3081801A (en) 1999-11-15 2001-05-30 Chemclean Corporation Bio-burden visualization system
PT1265550E (pt) 2000-03-10 2005-10-31 Mast Biosurgery Ag Micro reabsorvivel para atenuacao de tecido cicatricial
US7094874B2 (en) 2000-05-26 2006-08-22 Bristol-Myers Squibb Co. Soluble CTLA4 mutant molecules
AU2002211449A1 (en) 2000-10-04 2002-04-15 James Peter Amis Non-scatterable, radio-opaque marker for medical imaging applications
JP4653952B2 (ja) * 2001-12-07 2011-03-16 サイトリ セラピューティクス インコーポレイテッド 処理済み脂肪吸引細胞で患者を治療するためのシステムと方法
JP4749331B2 (ja) * 2003-10-07 2011-08-17 株式会社バイオマスター 脂肪由来前駆細胞の細胞分化

Also Published As

Publication number Publication date
DK1638507T3 (en) 2017-06-19
CN101415451A (zh) 2009-04-22
JP4722041B2 (ja) 2011-07-13
KR101145508B1 (ko) 2012-05-15
CA2529954A1 (en) 2005-02-10
WO2005011569A3 (en) 2009-04-02
JP2007536941A (ja) 2007-12-20
EP1638507A2 (en) 2006-03-29
KR20060025180A (ko) 2006-03-20
EP1638507B1 (en) 2017-03-22
WO2005011569A2 (en) 2005-02-10
AU2004260638A1 (en) 2005-02-10
EP1638507A4 (en) 2009-12-09

Similar Documents

Publication Publication Date Title
BRPI0411621A (pt) métodos de uso de células derivados de tecido adiposo no aumento de transferência de gordura autóloga
Dunn et al. Development of fibroblast‐seeded ligament analogs for ACL reconstruction
Utomo et al. Preparation and characterization of a decellularized cartilage scaffold for ear cartilage reconstruction
Vavken et al. TRITON‐X is most effective among three decellularization agents for ACL tissue engineering
KR20050085079A (ko) 분화되지 않은 중배엽 세포를 이용한 조직의 치료
Gardien et al. Progress towards cell-based burn wound treatments
BRPI0512831A (pt) construção de tecido liso, método para preparação de uma construção de tecido liso, uso da construção de tecido liso, e composição
KR101340458B1 (ko) 하이드로겔을 포함하는 연골 이식용 조성물
CN102716515B (zh) 一种修复半月板撕裂的生物材料及其制备方法
CR8126A (es) Metodo y dispositivo para tratar osteoartritis , enfermedad, defectos y lesiones del cartilago en la rodilla humana
BR0214021A (pt) Células estromais derivadas de tecido adiposo, composições e métodos para o uso de tais células no tratamento e reparo de qualquer defeito associado ao tecido ocular
KR20050014817A (ko) 자가 섬유아세포를 이용한 치료
Chen et al. Tissue engineering of tendons: a comparison of muscle-derived cells, tenocytes, and dermal fibroblasts as cell sources
Saczko et al. A simple and established method of tissue culture of human gingival fibroblasts for gingival augmentation.
Paredes et al. Innate tissue properties drive improved tendon healing in MRL/MpJ and harness cues that enhance behavior of canonical healing cells
CN103751844A (zh) 一种抗菌抗降解的猪小肠粘膜脱细胞基质制备方法及其应用
Wang et al. Hybrid hydrogel composed of hyaluronic acid, gelatin, and extracellular cartilage matrix for perforated TM repair
EP3101121B1 (en) Use of genetically modified odontogenic stem cells
Filipo et al. Rehabilitation of radical mastoidectomy
Xu et al. The use of allogenic adipose-derived stem cells in combination with platelet-rich fibrin for the treatment of cartilage defects in rabbit ear
Kadam et al. Treatment of gingival recession defect using human umbilical cord mesenchymal stem cells cultured on PCL based bone regenerating scaffold: a randomized controlled clinical study
CN112680409B (zh) 一种基于Wnt-5A/Ror2信号通路的软骨细胞增殖方法
Chu et al. Urine Derived Stem Cells as a Novel Cell Source for Urethral Tissue Regeneration
Silva-Carvalho et al. IBRUTINIB INDUCES ICAM-1 EXPRESSION ON MESENCHYMAL STEM CELLS AND ENHANCES THEIR POTENTIAL TO CONTROL T-CELL RESPONSE
Kratz et al. Tissue Engineering—Body Parts from the Petri Dish

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B15K Others concerning applications: alteration of classification

Ipc: C12N 5/0775 (2010.01), C12N 5/00 (2006.01), A61P 4

B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL